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Background: Epidemiological studies relate influenza infection with vascular diseases like myocardial infarction.
The hypothesis that influenza infection has procoagulant effects on humans has been investigated by experimental
animal models. However, these studies often made use of animal models only susceptible to adapted influenza
viruses (mouse adapted influenza strains) or remained inconclusive. Therefore, we decided to study the influence of
infection with human influenza virus isolates on coagulation in the well-established ferret influenza model.
Results: After infection with either a seasonal-, pandemic- or highly pathogenic avian influenza (HPAI-H5N1) virus
strain infected animals showed alterations in hemostasis compared to the control animals. Specifically on day 4 post
infection, a four second rise in both PT and aPTT was observed. D-dimer concentrations increased in all 3 influenza
groups with the highest concentrations in the pandemic influenza group. Von Willebrand factor activity levels increased
early in infection suggesting endothelial cell activation. Mean thrombin-antithrombin complex levels increased in both
pandemic and HPAI-H5N1 virus infected ferrets. At tissue level, fibrin staining showed intracapillary fibrin deposition
especially in HPAI-H5N1 virus infected ferrets.
Conclusion: This study showed hemostatic alterations both at the circulatory and at the tissue level upon infection
with different influenza viruses in an animal model closely mimicking human influenza virus infection. Alterations
largely correlated with the severity of the respective influenza virus infections.
Keywords: Influenza A virus (Human), H3N2 subtype, H1N1 subtype, H5N1 subtype, Consumption coagulopathyBackground
There are three manifestations of influenza in humans: sea-
sonal, avian and pandemic influenza. Seasonal influenza is
caused by influenza A or B viruses which infect 5-15% of
the human population every year [1,2]. Symptoms vary
from mild respiratory complaints to fatal respiratory
distress due to multiple organ failur. Symptoms depend
largely, however, on the health and immune status of
the infected individual and the pathogenicity of the spe-
cific virus involved. While avian influenza A viruses
cause sporadic zoonotic infections in humans, that do
not spread efficiently among humans [1], these infec-
tions may result in respiratory disease manifestations* Correspondence: m.goeijenbier@erasmusmc.nl
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article, unless otherwise stated.that range from mild to fatal, which among other variables
largely depends on the virulence of the virus involved. Al-
though most seasonal influenza virus infections are self-
limiting, they do cause a considerable burden of disease
that may be aggravated by complications of the infection
[3]. Patients with chronic illness are particularly at risk
of developing these complications when suffering from
(seasonal) influenza, like the observed increased risk for
developing cardiovascular disease during or shortly after
influenza virus infection [4]. This observation is supported
by the results of two intervention studies which showed a
risk reduction of myocardial infarction after influenza vac-
cination, which later was confirmed by a meta-analysis
carried out among 292,383 patients. This analysis showed
significant reductions in myocardial infarction, all-cause
mortality, and major adverse cardiac events in the influ-
enza vaccinated groups [5-7]. However, the etiologicalntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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poses for clinically relevant thrombotic disease has yet
to be determined. Current data suggest that influenza
virus infection causes an unbalanced coagulation mani-
fested by a procoagulant state (for review see [8-11]).
Indications for this increased clotting tendency have
come from clinical, experimental mouse and in vitro
data. Clinical reports range from mild increased coagu-
lation and fibrinolysis markers such as von Willebrand
factor (VWF) and D-dimer levels, to disseminated intra-
vascular coagulation observed in severe avian influenza
[12-14]. Experimental mouse data indicate a procoagulant
state characterized by increased thrombin generation, fi-
brin deposition, and an impaired fibrinolysis [15,16]. How-
ever, as the mouse is not a natural host to influenza virus,
mouse influenza models use mouse-adapted influenza vi-
ruses which cause a disease quite different from that of
human influenza [17]. Collectively experimental animal
studies and epidemiological data have largely remained in-
conclusive and cannot readily be translated into clinically
relevant conclusions.
The laboratory ferret (Mustela putorius furo) is not
only susceptible to human isolates of seasonal, avian and
pandemic influenza viruses, but pathogenesis and sever-
ity of the respective clinical manifestations of these in-
fections are to a large extent similar to those found in
humans [18,19]. Therefore, to address the hypothesis
that humans at risk for vascular disease may develop
clinically overt vascular thrombosis during or shortly
after influenza virus infection [20], we collected plasma
samples during a time course pathogenesis experiment
in which ferrets were infected with seasonal-, avian- or
pandemic influenza viruses [21]. Even though ferrets are
not generally considered to represent the high risk pa-
tients for vascular thrombotic disease, they do offer a
biologically variable and reliable animal model to ad-
dress the activation of coagulation during influenza virus
infection. Prothrombin time, activated partial thromboplas-
tin time, von Willebrand factor (VWF) activity, D-dimer
levels, and thrombin-antithrombin complexes were mea-
sured in sequentially collected plasma samples. In addition
fibrin staining was carried out on the lungs of infected
animals upon euthanasia to address the coagulation sta-
tus at the tissue level. All these parameters were evalu-
ated in relation to virological parameters and data on
disease severity.
Results
Clinical signs, pathology and virology of ferrets after
infection with H3N2-, pH1N1- or highly pathogenic H5N1
avian – influenza viruses
Clinical signs, pathological changes and virological param-
eters of this time course experiment in ferrets have been
reported previously [21]. Data important for this study aresummarized in Table 1. In short, clinical signs varied
greatly between the three influenza virus and mock in-
fected groups. All animals infected with H3N2, pH1N1,
or mock infection, survived the infections. H3N2 virus
infected ferrets showed mild clinical signs; nasal dis-
charge, sneezing, decreased tendency to eat, and body-
weight decrease by 11% (SD 8.5-13%) at 7 dpi. Detection
of infectious virus was restricted to the nose and peaked
at 1 dpi. Upon necropsy the lungs of the H3N2 infected
ferrets showed up to 10% consolidation by gross pathology
while the relative lung weights did not differ from the
controls.
Ferrets infected with the pH1N1 virus showed more
severe clinical signs compared to the seasonal H3N2
virus infected ferrets, with a body weight decrease
around 15% (SD 11.4-18.6%). Viral titers during pH1N1
virus infection also peaked at 1 dpi, but occurred at
similar levels throughout the whole respiratory tract.
One ferret in the pH1N1 group developed severe dys-
pnea. Relative lung weights increased compared to those
of the mock infected animals starting from day 1. Their
relative lung weights (weight of lung divided by body-
weight multiplied by 100) had increased from 0.6% (SD
0.57-0.65) to 1.3% (SD 1.0-1.6). The lungs of the pH1N1
virus infected ferrets showed up to 70% consolidation by
gross pathology.
The HPAI-H5N1 virus infected ferrets showed more
severe clinical signs with dyspnea leading to hypoxia. On
2.5 dpi, one animal died and one animal was euthanized
for ethical reasons. On 3 dpi, another animal died before
it could be euthanized. H5N1 virus was predominantly
found in the alveoli and viral titers peaked for a longer
period, from 1 to 3 dpi. Upon necropsy the lungs of the
H5N1 infected ferrets showed up to 100% consolidation
by gross pathology and relative lung weight was in-
creased up to 2.78% of total body weight, while pre-
inoculation samples had a mean relative lung weight of
0.66%. Mock infected ferrets showed no significant clin-
ical signs or weight loss. Only minor consolidations in
about 10% of the lung tissue were found upon necropsy.
To assess a potential link between hemostatic alter-
ations with total virus titers we generated the areas
under the curve (AUC) from the virus titer as shown in
Table 2.
Both prothrombin time and activated partial
thromboplastin time show transient prolongations during
influenza virus infection in ferrets
To evaluate tissue factor pathway activation of the co-
agulation cascade we tested the prothrombin time (PT)
for all samples. Before inoculation all ferrets had PTs
within normal range.
Figure 1 (row A) summarizes the PT results over time
for all four groups. For both the H3N2 virus and pH1N1
Table 1 Overview of the clinical data (bodyweight decrease, relative lung weight, lung damage) and virological
parameters (virus titers) partly adapted from Van den Brand et al. 2012 Plos One [21]
Day 1 2 3 4 7 14
Bodyweight H3N2 −51 −100 −69 −124 −186 −205
(16–86) (9–190) (33–104) (117–130) (141–231) (101–309)
pH1N1 −68 −169 −142 −250 −251 −193
(22–114) (161–176) (74–210) (185–315) (190–312) (19–368)
H5N1 −70 −131 −170 −190 ┼ ┼
(35–105) (112–149) (142–198) (135–246)
Control −44 −20 +7 −34 −62 −46
(31–57) (+30 - -69) (+40- -25) (+19 - -88) (+10 - -134) (+30 – 123)
Relative lung weight 10−2 gram H3N2 0.6 0.6 0.6 0.6 0.6 0.6
(0.5-0.7) (0.6-0.7) (0.5-0.6) (0.5-0.7) (0.6-0.7) (0.5-0.6)
pH1N1 0.8 1.0 1.1 1.2 1.3 0.7
(0.7-0.8) (0.9-1.2) (0.9-1.2) (1.1-1.3) (1.0-1.6) (0.6-0.8)
H5N1 0.9 1.4 1.7 2.4 ┼ ┼
(0.6-1.2) (1.1-1.7) (1.2-2.2) (2.0-2.7)
Control 0.7 0.7 0.6 0.6 0.6 0.6
(0.7-0.8) (0.6-0.8) (0.6-0.6) (0.6-0.7) (0.6-0.7) (0.5-0.7)
Lung damage % H3N2 3.8 2.5 0 0 0 1.3
(0–8.5) (0–5.4) (0–3.8)
pH1N1 22.5 25.0 40.0 45.0 47.5 25.0
(17.5-27.5) (19.2-30.8) (31.8-48.1) (35.0-55.0) (30.4-64.6) (19.2-30.8)
H5N1 25.0 55.0 62.5 77.5 ┼ ┼
(12.1-37.9) (35.9-74.2) (40.3-84.7) (55.3-99.7)
Control 3.8 6.3 6.3 1.3 5.0 3.8
(1.3-6.3) (1.5-11) (1.5-11) (0–3.8) (5–5) (1.3-6.3)
Turbinates/nasal concha log TCID50 H3N2 7.0 6.3 5.1 4.8 neg neg
(5.5-8.5) (5.4-7.3) (3.9-6.2) (3.4-6.1)
pH1N1 8.2 8.0 7.6 7.0 neg neg
(8.0-8.5) (7.7-8.3) (7.0-8.2) (6.2-7.9)
H5N1 4.8 5.0 5.6 4.9 ┼ ┼
(3.5-6.1) (4.4-5.6) (4.1-7.0) (3.4-6.4)
Trachea log TCID50 H3N2 2.4 neg neg neg neg neg
(<1.7-3.1)
pH1N1 5.5 5.4 5.9 5.5 neg neg
(5.0-6.0) (5.0-5.9) (5.6-6.3) (4.3-6.9)
H5N1 5.5 4.7 5.1 4.7 ┼ ┼
(4.7-6.3) (4.2-5.1) (4.1-6.2) (3.4-6.0)
Lung log TCID50 H3N2 neg Neg Neg neg neg neg
pH1N1 7.5 5.2 5.5 5.6 neg Neg
(7.2-7.8) (4.7-5.8) (5.1-6.0) (5.1-6.2)
H5N1 6.6 (6.0-7.2) 5.2 (4.7-5.6) 5.8 (5.5-6.1) 5.2 (4.7-5.6) ┼ ┼
Bodyweight decrease (+/− SD), relative lung weight, lung damage and viral titers (log TCID50 +/− SD) for lung, turbinates and trachea over time in H3N2, pH1N1
and H5N1 infected ferrets and the control (mock infection). Weight in grams, Lung damage in relative percentage of total lung tissue. Relative lung weight was
calculated by lung weight divided by bodyweight times 100%. Infectious virus titers in log10 TCID50/g threshold were based on Mock control and <1.8 for turbinates,
<1.9 for trachea, <1.4 log10 TCID50 for lung.
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Table 2 Viral parameters for correlation tests with
coagulation results from 0.5-4 dpi
Virus Day Virus titer* Lung virus AUC# Respiratory
tract AUC#
H3N2 0.5 3.5 (2.9-4.2) neg 0
1 7.0 (5.5-8.5) neg 2.6
2 6.3 (5.4-7.3) neg 9.3
3 5.1 (3.9-6.2) neg 15
4 4.8 (3.4-6.1) neg 19.9
pH1N1 0.5 26.0 (24.3-27.7) 0 0
1 31.7 (31.1-32.3) 3.6 14.4
2 27.0 (26.4-27.6) 10.0 43.8
3 27.0 (25.7-28.4) 15.4 70.8
4 25.7 (23.4-28.0) 20.1 97.1
H5N1 0.5 22.3 (19.5-25.2) 0 0
1 27.61 (24.4-30.8) 3.1 12.5
2 24.8 (22.3-27.3) 9.0 38.7
3 26.1 (22.0-30.8) 14.5 64.3
4 26.0 (23.9-28.0) 19.9 90.5
*Total virus titer in log TCID50 (cumulative titers of all organs with significant virus
titers: “lung, nasal concha, trachea, bronchus and bronchial lymph nodes”)
(+/− SD).
# AUC was calculated from virus titers curves. 7 dpi and 14 dpi were excluded
from the analysis because we data points from 5 & 6 dpi are not available
potentially resulting in over or underestimation of the true AUC.
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4 seconds at 4 dpi compared to pre-inoculation samples
(H3N2 p = 0.001, pH1N1 p = 0.02) and the mock in-
fected animals at the same day (H3N2 p = 0.03, pH1N1
p = 0.03). In the H5N1 infected ferrets, PT prolongation
started at 2 dpi with a prolongation up to 16 seconds in
individual animals. A clear trend is seen with PT in-
creasing up to 30 seconds at 3 dpi. On multiple occa-
sions ferrets died before samples could be drawn,
consequently the data depend on a small number of ob-
servations with a potentially strong survival bias. On 4
dpi only one sample met the quality criteria for PT test-
ing in the H5N1 group with a PT of 13.4 seconds, a
1.4 second increase compared to mean + SD from day 0
and mock samples (+/− SD). No significant changes in
PT were observed over time in the mock infected group.
Row B in Figure 1 shows the Activated partial thrombo-
plastin time (APTT) a measurement of the intrinsic
pathway of coagulation. APTT´s showed similar trends
as PT´s. At 4 dpi, APTT´s were prolonged in all the
three infected groups (Figure 1). H3N2 virus and pH1N1
virus infected ferrets showed mean APTT’s of 27.8
(26.1-29.6) and 24 (19.6-28.4) seconds respectively while
for the mock group this was 19.7 (18.5-20.9) seconds.
Paired testing showed that the pH1N1 virus infected fer-
rets had significantly prolonged APTT’s than the sam-
ples from pre inoculation (p = 0.02). No significantdifference was seen compared to the mock infected
group, potentially due to lack of power. Comparing 4
dpi samples with all pre-inoculation samples results in
significant differences for both H3N2 and pH1N1
(H3N2 p = 0.001 pH1N1 = 0.02). Three out of four fer-
rets inoculated with H3N2 and sacrificed at 4 dpi already
showed APTT prolongation before inoculation. This was
not observed in any of the other pre-inoculation sam-
ples, but hampers the interpretation of the significant
lengthening on 4 dpi compared to the mock infected
group (p = 0.03) resulting in a non-significant result in
paired sample testing. HPAI-H5N1 virus infected ferrets
showed a trend toward prolonged APTT on 3 dpi with a
mean of 28 (17.1-38.9) seconds and on 4 dpi 26.3 (17.3-
25.3) seconds, which was statistically significant when
compared to all APTT results in pre inoculation samples
(3 dpi p = 0.02, 4 dpi p = 0.02) .
Increased Von Willebrand factor activity during influenza
virus infection in ferrets suggests endothelial cell
activation
To study endothelial cell activation Von Willebrand
Factor activity (VWF) was measured. Figure 1 (row C)
summarizes the results indicating that, compared to
mock infection, VWF activity tends to early increase in
all three influenza virus infected groups. H3N2 virus in-
fected ferrets showed increased VWF activity from 2
dpi onward. Significant differences were observed at 2,
3 and 4 dpi compared with mock infected ferrets on
the same time points (2, 3 & 4 dpi, p = 0.028). Com-
pared to all day 0 samples, drawn before inoculation,
Mann Whitney U testing shows significant results for 3
and 4 dpi (3 dpi, p = 0.004 and 4 dpi, p = 0.003). For the
pH1N1 virus infected group mean VWF activity differed
significantly at 1 and 2 dpi compared to all pre-inoculation
samples (1 dpi, p = 0.0025, 2 dpi, p = 0.001). At these time
points, VWF activity was also significantly higher com-
pared to the pre-inoculation samples from the same ferrets
in paired testing (p = 0.03). HPAI-H5N1 virus infected ani-
mals showed trends of increased VWF activity early after
infection with highest levels seen at 1 (p = <0.05) and 2 dpi
(p = <0.05).
Increased D-dimer levels during influenza virus infection
in ferrets confirms a procoagulant state
D-dimer levels, fibrin degradation products that are
markers of both fibrinolysis and coagulation, were quan-
tified and results are listed in row D of Figure 1. Control
ferrets had relatively low D-dimer levels with a slight in-
crease the first days after inoculation and returning to
normal values at 7 dpi. This increase is most likely associ-
ated with the minor inflammation seen after inoculation
with the mock cell suspension. After infection, D-dimer
levels increased in all infected animals with the highest
Figure 1 PT (row A), APTT (row B), VWF activity (row C) and D-dimer levels (row D) in ferrets infected with mock, H3N2-, pH1N1- or
H5N1 influenza virus. Asterisk represents a p value < 0.05 in the paired samples (t = 0) or compared to the mock infection at the same time
point. All influenza variants lead to (transient) increases in PT and APTT. Differences were especially observed on day 4 post infection For PT 18
and for APTT 22 out of 208 samples could not be tested due to due to technical failure or insufficient plasma volumes. VWF increase is seen in all
three influenza virus groups, especially early after infection in pH1N1 and H5N1 virus infected ferrets with statistically significant results in the
earliest time points after infection. D-Dimer levels were raised in all 3 influenza groups with the highest levels seen in the pH1N1 virus infected
ferrets. X represents no data available since for H5N1 on day 7 and 14 no ferrets were alive.
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dimer levels were significantly higher in both the H3N2
and pH1N1 virus infected ferrets at all time points (H3N2
p = 0.028; pH1N1 p = 0.028) compared to the mock in-
fected group and to the pre-inoculation samples of the
same animals (H3N2 p = 0,005; pH1N1 p = 0.003). D-
dimer levels remained higher, compared to mock, until 7
dpi (H3N2 p = 0.028 pH1N1 p = 0.028). HPAI-H5N1 virus
infected animals showed significant increases compared to
the pre-inoculation samples (p = 0.005) on 2 dpi compared
to mock infected ferrets.
Plasma thrombin-antithrombin complexes are especially
increased after infection with highly pathogenic avian
influenza H5N1 virus
To further analyze activation of coagulation all ferrets
were tested for plasma thrombin-antithrombin (TAT)
complexes (Figure 2). Highest TAT levels were seen in
HPAI-H5N1 virus infected ferrets with a trend of in-
creased TAT generation. To analyze the total TAT for-
mation and compare to D-dimer formation during the
course of infection we combined all data from ½ to 4dpi of each group. This resulted in increased TAT levels
for both H1N1 and HPAI-H5N1 virus infected groups
(p = <0.05) and an increase in D-dimer formation during
all three influenza virus infections (panel E & F Figure 2).
Fibrin tissue staining suggests activation of coagulation
at tissue level
The Lendrum staining on alveolar lung tissues showed
predominantly the presence of fibrin deposition (orange-
red color) in many capillaries in the alveolar walls in the
HPAI-H5N1 virus infected group (Figure 3). Intermedi-
ate numbers of capillaries stained positive in the H3N2
virus infected group, a few capillaries of the pH1N1
virus infected group and in none in a negative control
sample from an uninfected ferret. However, the differ-
ences did not reach statistical significance when com-
pared to the mock infected group. The mock infected
group inoculated with uninfected cell derived material
did show minor signs of inflammation which were the
result of intra tracheal inoculation. This resulted in an
intermediate numbers of capillaries positive for fibrin
staining. In the slides stained for fibrin, there is no or
Figure 2 Thrombin-antithrombin complexes in ferrets infected with mock (A), H3N2 (B)-, pH1N (C)- or H5N1(D) influenza virus. Bar
represents median in scatterdot. Asterisk represents a p value < 0.05 in the paired samples (t = 0) or compared to the mock infection. E shows
mean TAT levels during the first episode of infection (day ½ to 4) F shows mean D-dimer levels during the first episode of infection (day ½ to 4).
Samples drawn before infection could not be analyzed due to exogenous TAT formation during venapuncture.
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chial submucosal glands with no significant difference
between the virus groups. Only in few pH1N1 and
H5N1 infected animals in rare lumina of bronchial sub-
mucosal glands there was little staining of fibrin, despite
the differences in inflammation within the glands be-
tween the viruses. The staining pattern in the capillaries
surrounding the bronchi is similar as that in the lung
parenchyma.
Comparison of coagulation parameters with virological
and disease severity data.
In HPAI-H5N1- and pH1N1 virus infected animals
VWF activity increased in the first two days after infec-
tion, coinciding with peak virus titers. D-dimer levels in-
creased during the first days after infection to peak at 3
and 4 dpi, when virus titers started to significantly de-
crease. In these animals, highest levels in clotting timeswere seen at 4 dpi when a peak in relative lung weights
was also observed. There was a significant correlation
between multiple parameters in all three influenza
groups (summarized in Table 2). Correlation analysis re-
vealed positive correlation between PT values and AUC
of the virus titers for the H3N2 virus (R = 0.8, p <0.01)
and pH1N1 virus (R = 0.7, p <0.01). D-dimer levels sig-
nificantly positively correlated with virus titer AUC and
body weight decrease for the pH1N1 virus infected
group. If we combine all data and thereby generate a
dataset from influenza A virus infected ferrets, signifi-
cant positive correlations can be seen between many of
the virological and clinical parameters compared to the
coagulation parameters. All significant R values are listed
in Table 3 with those of most interest being body weight
decrease with VWF, PT, APTT and D-dimer levels. Virus
titer AUC’s correlated significantly with PT, APTT and
D-dimer levels.
Figure 3 Lendrum staining expressing fibrin (red) in lung tissue of a control ferret or 4 days after inoculation of different influenza
viruses. No staining in a non-infected ferret (A), occasional intracappilairy staining of fibrin in ferrets inoculated with H3N2 (B) and pH1N1 (C),
and multifocal intracapillary staining in ferrets inoculated with H5N1 (D). Panel E shows the results of a semi-quantitative scoring of fibrin deposition
obtained by examining 25 images per slide.
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The present study demonstrates, for the first time, pro-
coagulant effects at the circulatory and tissue level in a
ferret influenza model, largely proportional to the sever-
ity of influenza virus infection. These findings are in line
with earlier epidemiological, clinical, animal and in vitro
data [6,8,13-15,20,22-24]. Ferrets have been shown to be
an adequate model to study the coagulation cascade
[25-27] with PT and APTT normal values varying from
11.6-12.7 and 18.9-22.3 seconds respectively. This is com-
parable to our 104 pre-inoculation ferret samples (PT 11.7
(+/− 0.1) and APTT 19.8 (+/− 2.2)) [26].
Like in humans, highly pathogenic avian influenza
virus infection causes severe disease in ferrets, which
may include bleeding complications and multi-organ
failure [28,29]. In our experiments, HPAI-H5N1 virus in-
oculated ferrets showed severe disease, which in some
cases resulted in spontaneous death. Analysis of the co-
agulation cascade in these animals confirmed the sever-
ity of infection with prolongation of global coagulationassays and signs of activated endothelium. PT and APTT
values increased already from 2 dpi onward with individ-
ual ferrets showing an increase up to 20 seconds. This
observation is suggestive for consumptive coagulopathy
which is strengthened by the high levels of fibrin depos-
ition in the lung capillaries. Consumptive coagulopathy
could be the result of extreme activation of coagulation,
for instance due to increased tissue factor production as is
seen in other (severe) viral diseases as Ebola hemorrhagic
fever [8]. The exact role for consumptive coagulopathy in
highly pathogenic H5N1 infection warrants further re-
search, but hypothetically the excess of coagulation activ-
ity could lead to microthrombosis in the pulmonary
alveoli leading to respiratory distress or even multi organ
failure [8]. The procoagulant changes were seen both at
the tissue level and in the circulation, suggested by the
TAT increase. The statistically significant increase in D-
dimer levels confirms this procoagulant state. However,
D-dimer levels were lower in HPAI-H5N1 virus inocu-
lated ferrets compared to ferrets infected with H3N2 virus
Table 3 Correlation between virological parameters and markers of hemostasis
Correlation H3N2 pH1N1 H5N1 H1N1 + H5N1 Influenza A
PT -Titer total# NS −0.6 (−0.9—0.1) * NS −0.5 (−0.75- -0.1)* NS
PT -AUC total# 0.8 (0.4-0.9)*** 0.7 (0.3-0.9)** NS 0.4 (0.1-0.7)* 0.4 (0.2-0.7)**
PT -Body weight NS 0.8 (0.4-0.9)** NS 0.5 (0.1-0.7)* 0.5 (0.2-0.7)**
PT -Lung weight NS 0.6 (0.05-0.9)* NS NS 0.4 (0.05-0.6)*
APTT -Titer total# −0.5 (−0.8 - -0.1)* NS NS NS NS
APTT -AUC total# 0.8 (0.6-0.9)*** NS NS NS 0.3 (0.05-0.6)*
APTT -Body weight NS 0.6 (0.2-0.9)** NS 0.5 (0.1-0.7)** 0.4 (0.2-0.6)**
APTT -Lung weight NS NS NS NS 0.3 (0.1-0.6)*
VWF-Titer total# −0.6 (−0.8-0.1)* NS NS NS NS
VWF-AUC total# 0.7 (0.4-0.9)** NS NS NS NS
VWF-Body weight NS NS NS NS 0.4 (0.1-0.6)*
VWF-Lung weight NS NS NS NS NS
D-dimer -Titer total# NS NS NS NS NS
D-dimer -AUC total# NS 0.6 (0.2-0.8)* NS 0.5 (0.1-0.7)* 0.4 (0.2-0.6 )**
D-dimer -Body weight NS 0.7 (0.2-0.9)** NS 0.5 (0.2-0.7)** 0.5 (0.2-0.7)***
D-dimer -Lung weight NS NS NS NS NS
TAT -Titer total# NS NS NS NS 0.3 (0.1-0.6)*
TAT -AUC total# NS NS NS NS NS
TAT -Body weight NS NS 0.6 (0.2-0.9)* NS NS
TAT -Lung weight NS NS NS 0.5 (0.1-0.7)** 0.3 (0.01-0.5)*
Virological parameters are listed in Table 1. For each influenza virus group coagulation values were correlated to virological and clinical parameters. This was also
done for the complete influenza A group (H3N2 + pH1N1 + H5N1) and for the combination of pH1N1 and H5N1 because these two viruses are able to infect the
complete respiratory tract instead of only the upper respiratory tract which is the case for H3N2.
Pearson correlation coefficients are given if the values were statistically significant. *p <0.05 **p < 0.01 ***P < 0.001 if not significant NS is listed in the table.
Using Bonferroni correction for multiple comparison significance threshold is lowered to p < 0.01. Therefore results marked with ** and *** are considered
statistically significant correlations.
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pH1N1 virus. A possible explanation for this phenomenon
could be the inhibition of fibrinolysis by high levels of
plasminogen-activator type 1 activity (PAI-1) during H5N1
virus infection. Unfortunately we could not test PAI-1 ac-
tivity in ferret plasma with the currently available human
PAI-1 activity assays. Since plasminogen is proven to play
an important role in influenza pathogenesis further explor-
ing the biology, activation and inhibition of plasminogen in
influenza infection would be of great interest [30].
The second virus we used in our experiments was
pH1N1. Although less severe compared to HPAI-H5N1
virus infected ferrets, pH1N1 virus infection caused se-
vere pneumonia with lung damage in ferrets. While fer-
rets infected with pH1N1 virus showed remarkably high
levels of D-dimer, tissue fibrin deposition was not as
prominent as seen in HPAI-H5N1 virus infected ferrets.
Activated coagulation in other organs than the respira-
tory tract or a systemic activation of coagulation could
explain this phenomenon. These severe procoagulant
changes in the circulation could be the result of a spe-
cific immune activation during pH1N1 virus infection. A
possible explanation can be found in the work ofMonsalvo et al. who showed an excessive amount of
pathogenic immune complexes, which are known to
have systemic procoagulant effects, in fatal pH1N1 cases
[31,32]. Furthermore, TAT levels significantly increased
in the first 4 days after infection and at 4 dpi there was a
remarkable prolongation of PT and APTT values up to
4 seconds. The very ‘sudden’ increase of clotting times at
4 dpi is suggestive for a consumptive coagulopathy, pos-
sibly similar to what was seen in DIC due to HPAI-
H5N1 virus infection and bacterial sepsis [33]. Clotting
times had normalized at 7dpi, however, indicating that
in contrast to bacterial sepsis, the consumptive coagu-
lopathy is transient and less severe. The ‘sudden’ onset
of clotting time prolongation may be of interest to evalu-
ate specific coagulation factor changes during influenza
infection.
To evaluate the influence of a more ‘moderate’ influ-
enza virus infection, seasonal H3N2 virus was also in-
cluded in the experiments. Although this influenza virus
in general causes ‘moderate’ disease in humans and fer-
rets, it did cause significant procoagulant changes in the
model with hemostatic alteration comparable to those of
pH1N1 virus infected ferrets. However, TAT levels did
Table 4 Distribution of the ferrets used in this study
Group P.I. ½ dpi 1 dpi 2 dpi 3 dpi 4 dpi 7 dpi 14 dpi X
Mock 28 4 4 4 4 4 4 4
H3N2 28 4 4 4 4 4 4 4
pH1N1 28 4 4 4 4 4 4 4
H5N1 20 4 4 4 4 4 0 0
Total 104 16 16 16 16 16 12 12
Z Y
Ferrets were sampled before inoculation with a mock control suspension, H3N2-,
pH1N1- or H5N1 influenza virus. Coagulation analysis values from the different
groups were compared using Mann–Whitney U test (X to Y). Subsequently values
from the predefined timepoints were analyzed with the pre inoculation (P.I.)
values using paired t-test (Y to Z).
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http://www.biomedcentral.com/1471-2180/14/134not increase suggesting a more moderate procoagulant state
compared to H1N1- and H5N1 virus infected animals.
Since the ageing human population is prone to both
an increase in cardiovascular disease and to complica-
tions during and after infection with seasonal and avian
influenza viruses [34,35], further exploration of the inter-
play between influenza and hemostasis would be of great
interest. Most of the associations found in Table 2 show
positive correlations between coagulation parameters
and markers of inflammation (body weight decrease and
relative lung weight increase). This comes as no surprise
since the bidirectional cross-talk between coagulation
and inflammation has been studied very well, whereby
inflammation in general evokes a procoagulant response
[36-38]. The specific disturbances in the tightly regulated
balance between clotting, anti-coagulation and inflam-
mation could be a target for novel intervention strategies
in influenza. Following our observational study, an inter-
vention model could further evaluate the role of coagu-
lation in influenza virus pathogenesis and the potential
processes for targeted intervention, for example by tar-
geting protease receptor type-2 (PAR-2) activation in in-
fluenza pathogenesis. PAR-2 is an important receptor in
both inflammation and coagulation, and recently de-
scribed to have a major role in the damage seen after the
inflammatory response during influenza virus infection
[39,40]. While statins may also be interesting candidates
for future studies. Statins may counteract specific in-
flammatory responses such as seen after acute coronary
syndrome, and thereby may decrease mortality when
given to influenza patients. Studying the influence of sta-
tin treatment on the procoagulant changes during influ-
enza virus infection and the role these changes have in
the postulated increased risk of myocardial infarction
would be of great interest [41-43].
Collectively the data generated by our study will pave
the way for further exploration of novel treatment and
intervention strategies for influenza and its complications.
Furthermore, based on the correlation between the viral
infection - and coagulation parameters in this experiment,
coagulation tests could serve as valuable biomarkers pre-
dicting disease severity. The ferret model likely offers the
best opportunity to explore these options in a preclinical
setting optionally also linked to host genetics since ferrets
represent an outbred population.
Conclusion
To our knowledge this is the first study that visualized
hemostatic alterations in influenza virus infection in a
controlled animal model resembling human disease. The
drastic changes seen in a very short time period might
be the result of consumptive coagulopathy. Interestingly
even in the seasonal influenza group, with only relatively
mild clinical ‘flu’ symptoms, infection had significanteffects on systemic hemostasis. These results might help
in further understanding the role of influenza infection
in acute cardiovascular disease, while future research
could indicate if alterations in coagulation have an im-
portant role in influenza pathogenesis.
Methods
Experimental design
Samples from 104, 11-month old, male, outbred ferrets
(Mustela putorius furo) were used for this experiment as
described previously [21]. Animals were inoculated both
intratracheally and intranasally with one of three influenza
viruses, or with control material (mock). All three influenza
virus strains had been directly derived from patient isolates.
For seasonal influenza, H3N2 virus (A/Netherlands/177/
2008) [18], for pandemic influenza, pH1N1 influenza
virus (A/Netherlands/602/2009) [44] and for highly
pathogenic avian influenza virus (HPAI) the H5N1 strain
(A/Indonesia/5/2005) were used [45]. Virus stocks were
passaged three times in Madin-Darby Canine Kidney
(MDCK) cells and titrated according to standard methods.
The viruses were clarified and reached an infectious virus
titer of 107.4 median tissue culture infectious dose (TCID50)
per ml for H3N2 virus, and 107.8 TCID50 for both pH1N1
and HPAI-H5N1 virus [46]. The inoculum of the control
group consisted of MDCK culture derived material which
had been subjected to the same procedure to control for
respiratory tract damage not related to replicating virus
[21]. Inocula consisted of 3 mL volumes of virus prepara-
tions with 106 TCID50 given per animal partly intratrache-
ally and partly intranasally. Ferrets were randomly selected
for any of the predefined time points before the start of the
experiment. Four ferrets were euthanized per time point.
Each ferret was sampled twice: before inoculation and
when sacrificed. This resulted in 104 samples analyzed be-
fore inoculation (28 mock, 28 H3N2, 28 pH1N1 and 20
H5N1) and 4 samples per virus per time point (Table 4).
During euthanasia, citrated blood was drawn by cardiac
puncture in 3 mL citrate tubes and plasma was prepared
for testing in coagulation assays.
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To reduce the numbers of experimental animals used, we
combined the earlier published influenza pathogenesis
study [21] with the current study addressing questions re-
lated to activation of coagulation and tissue fibrin depos-
ition during influenza virus infection. Animal housing and
experiments were all in compliance with European guide-
lines (EU directive on animal testing 86/609/EEC) and
Dutch legislation (Experiments on Animals Act, 1997) as
documented previously [21]. The study protocol was ap-
proved by the independent animal experimentation ethical
review committee of the Netherlands Vaccine Institute
(permit number 200900201). Animal welfare was observed
on a daily basis, and animal handling was performed
under light anesthesia using a mixture of ketamine and
medetomidine. After handling, atipamezole was adminis-
tered to antagonize the effect of medetomidine.
Coagulation assays
Prothrombin time (PT) and activated partial thromboplas-
tin time (APTT) were measured using a BCS-XP coagula-
tion analyzer (Siemens Healthcare Diagnostics) according
to the instructions of the manufacturer. Clotting was initi-
ated with Thromborel S (PT) and Pathrombin SL (APTT).
VWF ristocetin cofactor activity was also determined on
the BCS-XP with reagents of the manufacturer, and was
expressed as percentage of normal pooled human plasma.
Thrombin-antithrombin complexes (TAT, Siemens Health-
care Diagnostics) and D-dimer levels (Asserachrom, Roche,
The Netherlands) were measured using enzyme-linked
immunosorbent assay. All these assays were carried out
within the BSL-3 setting after careful calibration and
validation.
Pathology and fibrin staining
Gross pathology and histopathology were evaluated as
previously described [21]. Relative lung weight was used
as a validated measure of gross pathology and lung in-
flammation [47]. For detection of fibrin, tissues were
stained with the Lendrum staining according manufac-
turers’ protocol (MSB RRSK2-100 stain kit, Atom scien-
tific). On each slide a small piece of human placenta was
added as a positive control. Semi-quantitative assess-
ment of fibrin expression in the lungs was performed as
follows: for the alveoli, 25 arbitrarily chosen, 20x object-
ive, fields of lung parenchyma of one lung section were
examined by light microscopy for the presence of fibrin,
without the knowledge of the identity of the animals.
The scores (+ or -) were multiplied by 4 and presented
as percentage.
Virology
The presence of virus and virus replication in the re-
spiratory tract were measured by determining infectiousvirus titers at different sites of the upper respiratory tract
(URT) and lower respiratory tract (LRT). These results
were combined with data retrieved by measuring viral
antigen expression using standardized semi-quantitative
immunohistochemistry carried out at different sites of
the LRT as described previously [21].
Statistics
All statistical analyses were performed using the software
SPSS PASW statistics 17.0 and GraphPad Prism 4.01 for
Windows. The data were expressed as mean or median
with or without standard deviation or 95% confidence
interval as described in figure and table legends. The com-
pared groups are summarized in Table 4. The means per
time point between the influenza virus infected groups
and the mock control infected group were analyzed using
the Mann–Whitney U test. Furthermore, values at the
predefined time point of euthanasia were compared with
pre-inoculation samples using paired t-testing. Differences
with p ≤ 0.05 were considered statistically significant. For
comparison of individual association between virological
parameters and coagulation markers we used Pearson cor-
relation coefficient, and transformed to match a normal
distribution if needed. For correlation analysis we used
Bonferroni correction for multivariable comparison set-
ting p-value threshold to p ≤ 0.01.
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